203 related articles for article (PubMed ID: 36802665)
1. Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21.
Göricke F; Vu V; Smith L; Scheib U; Böhm R; Akkilic N; Wohlfahrt G; Weiske J; Bömer U; Brzezinka K; Lindner N; Lienau P; Gradl S; Beck H; Brown PJ; Santhakumar V; Vedadi M; Barsyte-Lovejoy D; Arrowsmith CH; Schmees N; Petersen K
J Med Chem; 2023 Mar; 66(5):3431-3447. PubMed ID: 36802665
[TBL] [Abstract][Full Text] [Related]
2. Insights Into the Properties, Biological Functions, and Regulation of USP21.
An T; Lu Y; Yan X; Hou J
Front Pharmacol; 2022; 13():944089. PubMed ID: 35846989
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of YOD1 and USP21 on the Hippo signaling pathway.
Park SS; Baek KH
Cancer Cell Int; 2023 Sep; 23(1):209. PubMed ID: 37743467
[TBL] [Abstract][Full Text] [Related]
4. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971
[TBL] [Abstract][Full Text] [Related]
5. Utilizing machine learning to identify nifuroxazide as an inhibitor of ubiquitin-specific protease 21 in a drug repositioning strategy.
Tak J; Nguyen TK; Lee K; Kim SG; Ahn HC
Biomed Pharmacother; 2024 May; 174():116459. PubMed ID: 38518599
[TBL] [Abstract][Full Text] [Related]
6. The USP21/YY1/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer.
Xu P; Xiao H; Yang Q; Hu R; Jiang L; Bi R; Jiang X; Wang L; Mei J; Ding F; Huang J
Exp Mol Med; 2020 Jan; 52(1):41-55. PubMed ID: 31956270
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitinating Enzyme USP21 Inhibits HIV-1 Replication by Downregulating Tat Expression.
Gao W; Li G; Zhao S; Wang H; Huan C; Zheng B; Jiang C; Zhang W
J Virol; 2021 Jun; 95(13):e0046021. PubMed ID: 33827943
[TBL] [Abstract][Full Text] [Related]
8. 20-hydroxyecdysone suppresses bladder cancer progression via inhibiting USP21: A mechanism associated with deubiquitination and degradation of p65.
Ma Q; Wu F; Liu X; Zhao C; Sun Y; Li Y; Zhang W; Ju H; Wang Y
Transl Oncol; 2024 Jul; 45():101958. PubMed ID: 38663220
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-specific protease 21 promotes tumorigenicity and stemness of colorectal cancer by deubiquitinating and stabilizing ZEB1.
Lin JJ; Lu YC
World J Gastrointest Oncol; 2024 Mar; 16(3):1006-1018. PubMed ID: 38577450
[TBL] [Abstract][Full Text] [Related]
10. Accelerating inhibitor discovery for deubiquitinating enzymes.
Chan WC; Liu X; Magin RS; Girardi NM; Ficarro SB; Hu W; Tarazona Guzman MI; Starnbach CA; Felix A; Adelmant G; Varca AC; Hu B; Bratt AS; DaSilva E; Schauer NJ; Jaen Maisonet I; Dolen EK; Ayala AX; Marto JA; Buhrlage SJ
Nat Commun; 2023 Feb; 14(1):686. PubMed ID: 36754960
[TBL] [Abstract][Full Text] [Related]
11. Discovery of the SMYD3 Inhibitor BAY-6035 Using Thermal Shift Assay (TSA)-Based High-Throughput Screening.
Gradl S; Steuber H; Weiske J; Szewczyk MM; Schmees N; Siegel S; Stoeckigt D; Christ CD; Li F; Organ S; Abbey M; Kennedy S; Chau I; Trush V; Barsyte-Lovejoy D; Brown PJ; Vedadi M; Arrowsmith C; Husemann M; Badock V; Bauser M; Haegebarth A; Hartung IV; Stresemann C
SLAS Discov; 2021 Sep; 26(8):947-960. PubMed ID: 34154424
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel USP8 inhibitors via Ubiquitin-Rho-110 fluorometric assay based high throughput screening.
Han J; Tian Y; Yu L; Zhang Q; Xu X; Zhang Y; Wang J; Ma Z; Bian J; Luo C; Jiang H; Chen K; Zhao Y; Li Z; Ding H
Bioorg Chem; 2020 Aug; 101():103962. PubMed ID: 32480171
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-Specific Protease 21 Promotes Colorectal Cancer Metastasis by Acting as a Fra-1 Deubiquitinase.
Yun SI; Hong HK; Yeo SY; Kim SH; Cho YB; Kim KK
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31947604
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of USP21 leads to ovarian carcinoma cell death by suppressing MAPK signaling.
Sun X; Yu J; Cui X; Tang Y; Yu Y
Biotechnol Appl Biochem; 2024 Feb; 71(1):232-239. PubMed ID: 37964466
[TBL] [Abstract][Full Text] [Related]
15. The deubiquitinase USP21 stabilizes MEK2 to promote tumor growth.
Li W; Cui K; Prochownik EV; Li Y
Cell Death Dis; 2018 May; 9(5):482. PubMed ID: 29706623
[TBL] [Abstract][Full Text] [Related]
16. USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation.
Hou P; Ma X; Zhang Q; Wu CJ; Liao W; Li J; Wang H; Zhao J; Zhou X; Guan C; Ackroyd J; Jiang S; Zhang J; Spring DJ; Wang YA; DePinho RA
Genes Dev; 2019 Oct; 33(19-20):1361-1366. PubMed ID: 31488580
[TBL] [Abstract][Full Text] [Related]
17. Monitoring Target Engagement of Deubiquitylating Enzymes Using Activity Probes: Past, Present, and Future.
Harrigan J; Jacq X
Methods Mol Biol; 2016; 1449():395-410. PubMed ID: 27613052
[TBL] [Abstract][Full Text] [Related]
18. Dissenting degradation: Deubiquitinases in cell cycle and cancer.
Bonacci T; Emanuele MJ
Semin Cancer Biol; 2020 Dec; 67(Pt 2):145-158. PubMed ID: 32201366
[TBL] [Abstract][Full Text] [Related]
19. USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase.
Fan Y; Mao R; Yu Y; Liu S; Shi Z; Cheng J; Zhang H; An L; Zhao Y; Xu X; Chen Z; Kogiso M; Zhang D; Zhang H; Zhang P; Jung JU; Li X; Xu G; Yang J
J Exp Med; 2014 Feb; 211(2):313-28. PubMed ID: 24493797
[TBL] [Abstract][Full Text] [Related]
20. Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7.
Lamberto I; Liu X; Seo HS; Schauer NJ; Iacob RE; Hu W; Das D; Mikhailova T; Weisberg EL; Engen JR; Anderson KC; Chauhan D; Dhe-Paganon S; Buhrlage SJ
Cell Chem Biol; 2017 Dec; 24(12):1490-1500.e11. PubMed ID: 29056421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
